Original Research Article
Year: 2017 | Month: October | Volume: 7 | Issue: 10 | Pages: 102-106
Strategic Analysis of Intellectual Property Rights Practices in Pharmaceuticals from India, China, and US
Shilpa A. Pise1, Ajay G. Pise2, Pramod G.Yeole3
1PhD Scholar, Institute of Pharmaceutical Education and Research (IPER), Borgaon (Meghe), Wardha, MS, India,
2Associate Professor, Dadasaheb Balpande College of Pharmacy, Besa, Nagpur, MS, India,
3Pro-Vice Chancellor, R.T.M. Nagpur University, Nagpur, MS, India,
Corresponding Author: Shilpa A. Pise
Aim: The study was conducted to compare the attitude of IPR (Intellectual Property Rights) experts about patent law in pharmaceuticals from India, China and US
Research methodology: This is a questionnaire based study to know the opinion of IPR experts from India, China and US. The purpose of this research is to know about patenting in Pharmaceuticals in India, China and US. Various factors were analysed about patenting in field of Pharmaceuticals.
Results and discussion: The answers of questionnaire were received by respondents and responses were analysed based on their answers. Various factors were analysed like impact of technology improvement, safety, efficacy, use, evergreening on pharmaceutical patenting.
Conclusion: Responses were highly appreciated to proceed the study and we came to know about different aspects of pharmaceutical patenting.
Key words: Pharmaceuticals, patentability aspects, patentability criteria, patent law